Team:BGU Israel/Achievements

Achievements

Biobricks

---

The following biobricks were designed, sent to the registry and characterized:

1. Bba_K1223002 – P.A.S.E 2 cassette
2. Bba_K1223003 - KanR (promoter+CDS)
3. Bba_K1223005 - cI translational unit
4. Bba_K1223006 - HisTag + stop codon
5. Bba_K1223007 - cI translational unit with His-tag
6. Bba_K1223011 - ampR translational unit (ampicilin resistance CDS+promoter)

The following biobricks were designed, characterized, and we currently work on sending them to the registry:

1. Bba_K1223001 – P.A.S.E 1 cassette
2. Bba_K1223013 - Pyrolysyl-tRNA synthetase CDS
3. Bba_K1223014 - tRNA-Pyl (pylT) gene from Methanosarcina barkeri str. Fusaro

In addition, we work on removing illegal restriction sites from pkd46 functional unit (Bba_K1223014). The biobrick itself works and was characterized.

P.A.S.E 1

---

1. The system’s parts have been designed and synthesized.
2. 2 out of 3 of the system’s parts have been assembled in e. coli – pkd78 (recombination system) and pUC57 cI (protective element)
3. Since we haven’t succeeded yet in proving the recombination system works, an alternative design was conceived for purposes of proof of concept, relying on the same principles as the original design. Instead of using a linear DNA with recombination sites for the toxin cassette, we used a plasmid as a cloning vector. The completed system was assembled and it is comprised of an e. coli transformed with pUC57 cI and pUC57 Toxin (toxin regulated by cI binding promoter). Characterizing the system is undergoing.
4. Characterization of P.A.S.E 1 cassette and collection of evidence regarding its lethal activity in the cells.
5. Characterizing the expression of cI repressor protein under the regulation of Lac/Ara-1 IPTG inducible promoter.
6. Construction of cI + his tag BioBrick.

P.A.S.E 2

---

1. The system’s parts have been designed and synthesized.
2. A recombination system (pkd78) with different antibiotic resistance have been constructed (we replaced the chloramphenicol resistance of pkd78 with carbenicillin resistance).
3. Site specific incorporation of Unnatural amino acids (UAA).
4. pKD + UAA machinery Transformed into BL-21 E. coli.
5. Creation of models of expected protein concentrations.

Attributions

---

All of the experimental work described here was performed only by the team, so as all the designing and assembly of the Bio Bricks. Prof. Lital Alfonta from the Avram and Stella Goldstein-Goren Department of Biotechnology Engineering of Ben Gurion University provided the laboratories we worked in this summer.

Collaboration

---

We helped Paris_Bettencourt team characterize one of their parts - Part: BBa_K1137008. This part codes for the enzyme TDMH, which degrades mycobacterial cell wall. The enzyme has a his tag, so we used Western blot to characterize its expression in BL21 over time – after 1, 2, 3 and 6 hours from induction with IPTG. Additionally, a negative control (an uninduced culture) was also used for the blotting.

We sent their team our part Bba_K1223005, so they could characterize the lac/ara-1 promoter we use in this construct.

Results coming soon!